Report on the risk assessment of N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF) in the framework of the Council Decision on new psychoactive substances 16. Červenec 2018, rubrika EUDA news
13. Únor 2026 Action on drug precursors: first EU-level precursor assessment reports published Illicit drug production poses a growing threat to public health and security in Europe. Monitoring drug precursor markets...
